13 Oct 2026, 09:15 IST
Emcure Pharmaceuticals Limited
Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)
The report states Emcure Pharmaceuticals approved the merger of its subsidiaries Zuventus Healthcare and Emcutix Biopharmaceuticals into the parent company as part of corporate restructuring.
From TATA MF Daily Market Monitor, written by Tata Asset Management Pvt. Ltd. (Tata Mutual Fund) and hosted by Tata Mutual Fund. Orivam summarised it; the view is Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)'s, not Orivam's.
Open the original PDF on Tata Mutual Fund →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.